Next Article in Journal
Pharmacy and Travel Medicine: A Global Movement
Next Article in Special Issue
Experiences of the Pharmacy-Led Weight Management Service: Views of Service Providers in England
Previous Article in Journal
Competency and Its Many Meanings
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessCommunication

Emergency Contraception Counseling in California Community Pharmacies: A Mystery Caller Study

Department of Pharmacy, UC San Diego Health, San Diego, CA 92103, USA
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA
Birth Control Pharmacist, San Diego, CA 92122, USA
Owl Rexall Drug, Glendora, CA 91740, USA
Office of Population Research, Woodrow Wilson School of Public and International Affairs, Princeton University, Princeton, NJ 08540, USA
Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
Children’s Health Services Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Author to whom correspondence should be addressed.
Pharmacy 2019, 7(2), 38;
Received: 18 February 2019 / Revised: 5 April 2019 / Accepted: 15 April 2019 / Published: 23 April 2019
(This article belongs to the Special Issue The Role of Community Pharmacists in Public Health)
PDF [546 KB, uploaded 8 May 2019]


This study was conducted to determine which emergency contraception (EC) methods are offered by community pharmacists in response to patient calls. Female mystery callers called all community pharmacies in two California cities using standardized scripts. The callers inquired about options available to prevent pregnancy after sex and whether that method was available at the pharmacy, using follow-up probes if necessary. A total of 239 calls were completed in San Diego (n = 127, 53%) and San Francisco (n = 112, 47%). Pharmacists indicated availability at most sites (n = 220, 92%) with option(s) reported as levonorgestrel only (LNG; n = 211, 88.3%), both ulipristal acetate (UPA) and LNG (n = 4, 1.6%), UPA only (n = 1, 0.4%), or non-specific EC (n = 4, 1.7%). Nineteen pharmacies (7.9%) did not have EC available on the day of the call. Following additional probing, some pharmacists discussed UPA (n = 49, 20.5%) or the copper intrauterine device (n = 1, 0.4%) as EC options. LNG EC products were available same-day in 90.1% of pharmacies, whereas UPA was available same-day in 9.6% of pharmacies. The majority of pharmacies called in this study offered and stocked at least one EC option, but the focus of discussions was on LNG and matched what was in stock and available. View Full-Text
Keywords: emergency contraception; levonorgestrel; ulipristal acetate; pharmacy; pharmacist emergency contraception; levonorgestrel; ulipristal acetate; pharmacy; pharmacist

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Ditmars, L.; Rafie, S.; Kashou, G.; Cleland, K.; Bayer, L.; Wilkinson, T.A. Emergency Contraception Counseling in California Community Pharmacies: A Mystery Caller Study. Pharmacy 2019, 7, 38.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top